Skip to content

World Viscosupplementation Market Report 2022: Growing Incidence of Osteoarthritis Bolsters Development –

DUBLIN–(BUSINESS WIRE)–The “World Viscosupplementation Market, Dimension, World Forecast 2023-2028, Business Traits, Development, Affect of Inflation, Alternative Firm Evaluation” report has been added to’s providing.

World Viscosupplementation Market is predicted to succeed in US$ 6.27 Billion by 2028 in line with the writer. Sufferers with osteoarthritis have a minimally invasive therapeutic choice referred to as viscosupplementation.

Throughout viscosupplementation, hyaluronic acid is pushed into the joints. The synovial fluid that covers joints incorporates hyaluronic acid, a substance that happens naturally. It lubricates joints to permit bones to maneuver freely and fewer discomfort. Hyaluronic acid ranges within the joints are decrease in these with osteoarthritis, which causes ache.

In accordance with the analysis findings, Worldwide Viscosupplementation market was US$ 3.71 Billion in 2022.

World Viscosupplementation Market will develop with 9.14% CAGR in the course of the forecast interval:

The rise within the incidence of osteoarthritis, the rise within the geriatric inhabitants, and the hike within the variety of product launches and product approvals are the principle components driving the expansion of the worldwide viscosupplementation market measurement. One of the prevalent kinds of arthritis is osteoarthritis.

In 2019, the Facilities for Illness Management and Prevention estimated that 32.5 million People (1 in 7 adults) had osteoarthritis. As a consequence of a rise in power illnesses like weight problems, diabetes, and coronary heart illness, the prevalence of osteoarthritis has reached alarming ranges. Moreover, a scarcity of bodily exercise, corresponding to train, will increase the requirement for osteoarthritis therapy for the knee and hip and propels market growth.

Single Injection Viscosupplementation holds the lion’s share

By process, the Viscosupplementation market is split into three segments, ie, Single Injection Viscosupplementation, Three Injection Viscosupplementation, and 5 Injections Viscosupplementation. Amongst all, Single Injection dominates the present viscosupplementation market. The demand for outpatient surgical procedures that provide same-day surgical care, together with preventive (surgical) and diagnostic procedures, is driving the Single Injections Section. Moreover, a rise in product launches and give attention to creating single injections for the therapy of osteoarthritis are anticipated to contribute to the numerous development of the single-injection market over the forecast interval.

By Software: The Knee Osteoarthritis Section dominates the Market Share

Because of the elevated prevalence of knee osteoarthritis and the rising geriatric inhabitants, who’re extra weak to knee osteoarthritis, the knee osteoarthritis section dominated the Viscosupplementation market and is anticipated to take care of this development over the projected interval. As well as, the getting old impact, which reduces the quantity of water in cartilage and additional reduces its capability to soak up shock and cushion, makes the aged inhabitants extra inclined to creating knee osteoarthritis.

Orthopedic clinics/Ambulatory Surgical Facilities Section is rising at a Vital Development Charge

By Finish customers, the Viscosupplementation market is segmented into Hospitals and Orthopedic clinics/Ambulatory Surgical Facilities. Outpatient service websites, significantly people who present ambulatory surgical procedure and doctor office-based remedies, have grown into fierce opponents for hospitals because of the current adoption of value-based care. Orthopedic clinics/Ambulatory Surgical Facilities provide each sensible and monetary advantages, corresponding to faster affected person entry, extra reasonably priced costs, extra alternatives for doctor involvement, and outpatient services. Therefore they purchase a dominant market share within the Viscosupplementation market.

By Area: North America and Asia Pacific holds a Vital Market Share

North America occupies a dominant place within the international viscosupplementation market. The components contributing to the expansion of viscosupplementation within the North American area are the elevated prevalence of osteoarthritis and associated remedies, the getting old inhabitants, the well-established healthcare system, and the rising want for non-surgical procedures. Moreover, Asia Pacific is predicted to develop with a outstanding development price in the course of the forecast interval because of the improve within the geriatric inhabitants and rising healthcare expenditures.

Market Segmentation


1. Single Injection Viscosupplementation

2.Three Injections Viscosupplementation

3. 5 Injections Viscosupplementation


1.Knee Osteoarthritis

2.Hip Osteoarthritis

3. Hand/Wrist Osteoarthritis

4. Ankle/Foot Osteoarthritis


Finish Person


2. Orthopedic clinics/Ambulatory Surgical Facilities


1. North America


3. Asia Pacific

4. Remainder of World

Key Gamers

1. Anika Therapeutics Inc.

2. Sanofi

3.Zimmer Biomet

4.Smith & Nephew PLC

5.Lifecore Biomedical

6. LG Life Sciences Ltd.

7. F. Hoffmann-La Roche Ltd.

8. Chugai Pharmaceutical Co.

Key Subjects Lined:


2.Analysis & Methodology

3.Govt Abstract

4.Market Dynamics

5. World Viscosupplementation Market

6. Market Share – World Viscosupplementation Evaluation

7. Product – World Viscosupplementation Market

8. Software – World Viscosupplementation Market

9. Finish Person – World Viscosupplementation Market

10. Area – World Viscosupplementation Market

11.Firm Evaluation

For extra details about this report go to is the world’s main supply for worldwide market analysis reviews and market information. We give you the most recent information on worldwide and regional markets, key industries, the highest firms, new merchandise and the most recent developments.

Leave a Reply

Your email address will not be published. Required fields are marked *